BSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.
Shelter Pharma Ltd: key numbers
- Share price
- ₹40.50
- Market cap
- ₹70.07 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 7.8×Sector 48.7×
- Promoter holding
- 46.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma Bags ₹0.22 Cr Order from First Vet Veterinary Medicines Trading L.L.C
Shelter Pharma won a USD 23,300 (Rs 0.22 Crore) export order from First Vet, UAE. Ordinary course business, executable per the purchase order schedule.
- Value
- ₹0.22 Cr
- From
- First Vet Veterinary Medicines Trading L.L.C
- Execution
- Within the mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹0.1 Cr Order from Genet International
Shelter Pharma won a Rs.0.10 Crore order from Genet International in Bangladesh. It covers 10,000 boxes in the normal course of business.
- Value
- ₹0.10 Cr
- From
- Genet International
- Execution
- Within mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹3.15 Cr Order from Taha Drugs & Chemicals Co. Ltd.
Shelter Pharma Ltd received an international order from Taha Drugs & Chemicals Co. Ltd. worth Rs.3.15 Crore (USD 3,30,975). Execution follows mutually agreed purchase order schedules.
- Value
- ₹3.15 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.
- Execution
- Within mutually agreed timelines as per purchase order schedule
Shelter Pharma Bags ₹3.47 Cr Order from Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines...
Shelter Pharma received export orders worth Rs. 3.47 Crore from three overseas buyers. Execution follows mutually agreed purchase-order schedules, in the normal course of business.
- Value
- ₹3.47 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines Trading L.L.C; Genet International
- Execution
- As per mutually agreed purchase order schedules
Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its shareholding pattern under Regulation 31(1)(c). The filing reports promoter, public and category-wise holdings without any transaction.
Shelter Pharma Preferential Issue
Shelter Pharma Ltd has allotted 4,65,000 equity shares via a preferential issue at ₹42.25 per share. This transaction resulted in a total capital infusion of ₹1.96 Crore.
- Value
- ₹1.96 Cr
Other capacity expansion announcements
All →Aditya Vision Capacity Expansion
Aditya Vision opened five new showrooms, taking its total to 219. The expansion enters Madhya Pradesh and West Bengal, its fifth and sixth states.
- new showrooms
- 5.0 showrooms
FlySBS Aviation Capacity Expansion: ₹13.98 Cr Investment
FlySBS Aviation will induct a Hawker 900XP 9-seater aircraft in October 2026, funded by Rs.13.98 Crore from IPO proceeds. Fleet rises from two to three aircraft.
- Value
- ₹13.98 Cr
- Execution
- October 2026
- fleet capacity (9-seater aircraft)
- 1.0 aircraft
Greenply Industries Capacity Expansion: ₹30 Cr Investment
Greenply's board approved further investment of up to INR 30 crore in its wholly owned subsidiary Greenply Sandila Private Limited for plywood capacity expansion. The funds will be paid in one or more tranches by Q4 FY2028.
- Value
- ₹30.00 Cr
- Execution
- Q4 of FY 2028, in one or more tranches
Ethos Capacity Expansion
Ethos has opened a new Ethos Summit boutique at Fort, Mumbai, taking its total to 105 boutiques across India. The filing is an update on a store opening with no monetary value disclosed.
- new boutiques
- 1.0 boutiques
Greenply Industries Capacity Expansion
Greenply's board noted a 15 million sq mtr plywood capacity expansion at subsidiary Greenply Sandila, due by Q4 FY2028. Approximately Rs. 125 crore investment is planned.
- Execution
- By Q4 of FY 2028
- plywood manufacturing capacity
- 15.0 million sq mtr
Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment
Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹20.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.7 Bn units